Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biosafety evidence for human dedifferentiated adipocytes.
Poloni A, Maurizi G, Mattiucci D, Busilacchi E, Mancini S, Discepoli G, Amici A, Falconi M, Cinti S, Leoni P. Poloni A, et al. Among authors: amici a. J Cell Physiol. 2015 Jul;230(7):1525-33. doi: 10.1002/jcp.24898. J Cell Physiol. 2015. PMID: 25641257
A novel 3'-tRNAGlu-derived fragment acts as a tumor suppressor in breast cancer by targeting nucleolin.
Falconi M, Giangrossi M, Zabaleta ME, Wang J, Gambini V, Tilio M, Bencardino D, Occhipinti S, Belletti B, Laudadio E, Galeazzi R, Marchini C, Amici A. Falconi M, et al. Among authors: amici a. FASEB J. 2019 Dec;33(12):13228-13240. doi: 10.1096/fj.201900382RR. Epub 2019 Sep 27. FASEB J. 2019. PMID: 31560576
Here, we provide evidence that tRF3E plays an important role in the pathogenesis of BC displaying tumor-suppressor functions through a NCL-mediated mechanism.-Falconi, M., Giangrossi, M., Elexpuru Zabaleta, M., Wang, J., Gambini, V., Tilio, M., Bencardino, D., Occhipinti, …
Here, we provide evidence that tRF3E plays an important role in the pathogenesis of BC displaying tumor-suppressor functions through a …
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib.
Tilio M, Gambini V, Wang J, Garulli C, Kalogris C, Andreani C, Bartolacci C, Elexpuru Zabaleta M, Pietrella L, Hysi A, Iezzi M, Belletti B, Orlando F, Provinciali M, Galeazzi R, Marchini C, Amici A. Tilio M, et al. Among authors: amici a. Cancer Lett. 2016 Oct 10;381(1):76-84. doi: 10.1016/j.canlet.2016.07.028. Epub 2016 Jul 27. Cancer Lett. 2016. PMID: 27475932
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer.
Wang J, Lamolinara A, Conti L, Giangrossi M, Cui L, Morelli MB, Amantini C, Falconi M, Bartolacci C, Andreani C, Orlando F, Provinciali M, Del Pizzo FD, Russo F, Belletti B, Riccardo F, Bolli E, Quaglino E, Cavallo F, Amici A, Iezzi M, Marchini C. Wang J, et al. Among authors: amici a. Cancers (Basel). 2022 Aug 22;14(16):4054. doi: 10.3390/cancers14164054. Cancers (Basel). 2022. PMID: 36011047 Free PMC article.
Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer.
Citron F, Segatto I, Vinciguerra GLR, Musco L, Russo F, Mungo G, D'Andrea S, Mattevi MC, Perin T, Schiappacassi M, Massarut S, Marchini C, Amici A, Vecchione A, Baldassarre G, Belletti B. Citron F, et al. Among authors: amici a. Cancer Res. 2020 Mar 1;80(5):1064-1077. doi: 10.1158/0008-5472.CAN-19-1793. Epub 2019 Dec 20. Cancer Res. 2020. PMID: 31862778
311 results